Scilex Holding Company Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Scilex Holding Company stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $82.00K, a 77.09% decline year-over-year.
- Scilex Holding Company stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $99.00K, a 55.41% decline year-over-year.
- Scilex Holding Company stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $46.00K.
- Scilex Holding Company stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $358.00K.
- Scilex Holding Company stock issued during period, value, stock options exercised for fiscal 2024 was $227.00K, a 63.03% decline from fiscal 2023.
- Scilex Holding Company stock issued during period, value, stock options exercised for fiscal 2023 was $614.00K, a 539.58% increase from fiscal 2022.
- Scilex Holding Company stock issued during period, value, stock options exercised for fiscal 2022 was $96.00K.
- Scilex Holding Company stock issued during period, value, stock options exercised for fiscal 2020 was $50.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $227.00K 10-K · filed 2026-04-10 | |
| 2024-09-30 | $82.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $99.00K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $46.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $614.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $358.00K 10-Q · filed 2025-01-17 | |
| 2023-06-30 | $222.00K 10-Q · filed 2025-01-17 | |
| 2022-12-31 | $96.00K 10-K · filed 2024-03-12 | |
| 2022-03-31 | $96.00K 10-Q · filed 2023-11-14 | |
| 2020-12-31 | $50.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |